India's Zydus Lifesciences reported third-quarter profit above analysts' expectations on Wednesday, driven by strong demand for its generic drugs in its key U.S. market.
Over a hundred companies, including Swiggy and Reliance Power, will announce quarterly earnings. The Indian stock market ...
Microlending platform Salus will leverage authID’s technology to provide applicants with intuitive and data-secure authenticationDENVER, Feb.
The Quarterly Results page of Zydus Lifesciences Ltd. presents the key result items, its comparison with the sector peers and its previous 5 Quarterly Results.
Dr Reddy’s, Zydus, Cipla, Sun can sustain low-double digit EPS growth over medium term: Bino Pathiparampil Indian pharma companies like Dr Reddy’s, Zydus, Cipla, and Sun can sustain low double-digit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback